• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全细胞疫苗候选物能诱导针对强毒的保护性应答。

Whole-cell vaccine candidates induce a protective response against virulent .

机构信息

Biological Mimetics, Inc., Frederick, MD, United States.

Wound Infections Department, Bacterial Diseases Branch, Center for Infectious Disease Research, Walter Reed Army Institute of Research, Silver Spring, MD, United States.

出版信息

Front Immunol. 2022 Sep 27;13:941010. doi: 10.3389/fimmu.2022.941010. eCollection 2022.

DOI:10.3389/fimmu.2022.941010
PMID:36238282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9553005/
Abstract

causes multi-system diseases in both nosocomial settings and a pre-disposed general population. The bacterium is not only desiccation-resistant but also notoriously resistant to multiple antibiotics and drugs of last resort including carbapenem, colistin, and sulbactam. The World Health Organization has categorized carbapenem-resistant at the top of its critical pathogen list in a bid to direct urgent countermeasure development. Several early-stage vaccines have shown a range of efficacies in healthy mice, but no vaccine candidates have advanced into clinical trials. Herein, we report our findings that both an ionizing γ-radiation-inactivated and a non-ionizing ultraviolet C-inactivated whole-cell vaccine candidate protects neutropenic mice from pulmonary challenge with virulent AB5075, a particularly pathogenic isolate. In addition, we demonstrate that a humoral response is sufficient for this protection the passive immunization of neutropenic mice.

摘要

导致医院环境和易感染人群发生多系统疾病。该细菌不仅具有抗干燥能力,而且对多种抗生素和最后手段的药物(包括碳青霉烯类、黏菌素和舒巴坦)具有明显的耐药性。世界卫生组织已将耐碳青霉烯类肠杆菌科细菌列为其关键病原体清单的首位,旨在指导紧急对策的制定。几种早期疫苗在健康小鼠中显示出了不同的疗效,但没有疫苗候选者进入临床试验。在此,我们报告发现,经电离γ 射线灭活和非电离紫外线 C 灭活的全细胞候选疫苗均能保护中性粒细胞减少症小鼠免受强毒 AB5075 的肺部攻击,AB5075 是一种特别具有致病性的分离株。此外,我们还证明了体液反应足以提供这种保护——中性粒细胞减少症小鼠的被动免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c471/9553005/f5cd8be75b98/fimmu-13-941010-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c471/9553005/7271548cb4c9/fimmu-13-941010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c471/9553005/f54b07bf34cf/fimmu-13-941010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c471/9553005/2434693062cf/fimmu-13-941010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c471/9553005/f5cd8be75b98/fimmu-13-941010-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c471/9553005/7271548cb4c9/fimmu-13-941010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c471/9553005/f54b07bf34cf/fimmu-13-941010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c471/9553005/2434693062cf/fimmu-13-941010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c471/9553005/f5cd8be75b98/fimmu-13-941010-g004.jpg

相似文献

1
Whole-cell vaccine candidates induce a protective response against virulent .全细胞疫苗候选物能诱导针对强毒的保护性应答。
Front Immunol. 2022 Sep 27;13:941010. doi: 10.3389/fimmu.2022.941010. eCollection 2022.
2
Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.多黏菌素 E/舒巴坦联合应用增强对碳青霉烯类耐药鲍曼不动杆菌的杀菌作用。
Int J Antimicrob Agents. 2021 Feb;57(2):106271. doi: 10.1016/j.ijantimicag.2020.106271. Epub 2020 Dec 23.
3
[Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].[多黏菌素/舒巴坦联合用药对耐碳青霉烯类鲍曼不动杆菌菌株的疗效评估]
Mikrobiyol Bul. 2016 Jul;50(3):460-5. doi: 10.5578/mb.26289.
4
Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.基于碳青霉烯类的联合用药对多重耐药鲍曼不动杆菌的抗菌活性
J Med Assoc Thai. 2010 Feb;93(2):161-71.
5
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.碳青霉烯/舒巴坦合剂、多黏菌素、多黏菌素/利福平合剂及替加环素对耐碳青霉烯鲍曼不动杆菌的体外活性
J Antimicrob Chemother. 2007 Aug;60(2):317-22. doi: 10.1093/jac/dkm136. Epub 2007 May 31.
6
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.黏菌素与替加环素或β-内酰胺类抗生素/β-内酰胺酶抑制剂组合对耐碳青霉烯类鲍曼不动杆菌的体外协同活性。
J Int Med Res. 2013 Dec;41(6):1830-7. doi: 10.1177/0300060513496172.
7
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.耐黏菌素鲍曼不动杆菌:超越碳青霉烯类耐药性
Clin Infect Dis. 2015 May 1;60(9):1295-303. doi: 10.1093/cid/civ048. Epub 2015 Jan 28.
8
Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.亚胺培南西司他丁钠、多黏菌素 E 硫酸盐与替加环素联合应用对碳青霉烯类耐药鲍曼不动杆菌脓毒症模型的疗效。
Chemotherapy. 2013;59(5):325-9. doi: 10.1159/000356755. Epub 2014 Feb 13.
9
In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.替加环素单独及与硫酸黏菌素或舒巴坦联合应用对从重症监护病房分离出的对碳青霉烯类敏感及耐药的鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2010 Aug;36(2):191-2. doi: 10.1016/j.ijantimicag.2010.04.004. Epub 2010 May 26.
10
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.耐多粘菌素、耐碳青霉烯类鲍曼不动杆菌可被三种单独无活性的药物联合使用所根除。
J Antimicrob Chemother. 2017 May 1;72(5):1415-1420. doi: 10.1093/jac/dkx002.

引用本文的文献

1
Immune and Safety Analysis of IPV, a Novel UVC-Inactivated Polio Vaccine.新型紫外线灭活脊髓灰质炎疫苗(IPV)的免疫和安全性分析
Viruses. 2025 Jun 27;17(7):915. doi: 10.3390/v17070915.
2
The ternary complex of Mn, synthetic decapeptide DP1 (DEHGTAVMLK), and orthophosphate is a superb antioxidant.锰、合成十肽DP1(DEHGTAVMLK)和正磷酸盐的三元复合物是一种极好的抗氧化剂。
Proc Natl Acad Sci U S A. 2024 Dec 17;121(51):e2417389121. doi: 10.1073/pnas.2417389121. Epub 2024 Dec 12.
3
A highly immunogenic UVC inactivated Sabin based polio vaccine.

本文引用的文献

1
Select Whole-Cell Biofilm-Based Immunogens Protect against a Virulent Staphylococcus Isolate in a Stringent Implant Model of Infection.选择基于全细胞生物膜的免疫原可在严格的植入物感染模型中抵御强毒力葡萄球菌分离株。
Vaccines (Basel). 2022 May 24;10(6):833. doi: 10.3390/vaccines10060833.
2
Vaccine development to control the rising scourge of antibiotic-resistant : a systematic review.控制抗生素耐药性这一日益严重祸害的疫苗研发:一项系统综述。
3 Biotech. 2022 Mar;12(3):85. doi: 10.1007/s13205-022-03148-9. Epub 2022 Mar 2.
3
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
一种具有高度免疫原性的基于萨宾株的紫外线灭活脊髓灰质炎疫苗。
NPJ Vaccines. 2024 Nov 14;9(1):217. doi: 10.1038/s41541-024-00995-w.
4
The Comparative Characterization of a Hypervirulent Bacteremia Clinical Isolate Reveals a Novel Mechanism of Pathogenesis.一株强毒力菌血症临床分离株的比较特征分析揭示了一种新的致病机制。
Int J Mol Sci. 2024 Sep 10;25(18):9780. doi: 10.3390/ijms25189780.
5
Influenza Virus Inactivated by Heavy Ion Beam Irradiation Stimulates Antigen-Specific Immune Responses.重离子束辐照灭活的流感病毒刺激抗原特异性免疫反应。
Pharmaceutics. 2024 Mar 27;16(4):465. doi: 10.3390/pharmaceutics16040465.
6
Hit 'em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target.击中痛点:革兰氏阴性菌脂多糖作为疫苗靶点。
Microbiol Mol Biol Rev. 2023 Sep 26;87(3):e0004522. doi: 10.1128/mmbr.00045-22. Epub 2023 Jul 11.
2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
4
Small-Molecule Mn Antioxidants in Caenorhabditis elegans and Deinococcus radiodurans Supplant MnSOD Enzymes during Aging and Irradiation.小分子锰抗氧化剂在秀丽隐杆线虫和耐辐射球菌中替代 MnSOD 酶在衰老和辐射过程中的作用。
mBio. 2022 Feb 22;13(1):e0339421. doi: 10.1128/mbio.03394-21. Epub 2022 Jan 11.
5
Infections in Times of COVID-19 Pandemic.新冠疫情时期的感染情况
Pathogens. 2021 Aug 10;10(8):1006. doi: 10.3390/pathogens10081006.
6
Control and management of multidrug resistant : A review of the evidence and proposal of novel approaches.多重耐药的控制与管理:证据综述及新方法建议
Infect Prev Pract. 2020 Jul 19;2(3):100077. doi: 10.1016/j.infpip.2020.100077. eCollection 2020 Sep.
7
Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies.疫苗研发:过去、现在和未来,包括新的治疗策略。
Front Immunol. 2021 Jul 7;12:705360. doi: 10.3389/fimmu.2021.705360. eCollection 2021.
8
Mapping Global Prevalence of and Recent Vaccine Development to Tackle It.绘制全球流行情况以及应对该情况的近期疫苗研发进展。
Vaccines (Basel). 2021 Jun 1;9(6):570. doi: 10.3390/vaccines9060570.
9
Designing Multi-Antigen Vaccines Against Using Systemic Approaches.利用系统方法设计针对 的多抗原疫苗。
Front Immunol. 2021 Apr 16;12:666742. doi: 10.3389/fimmu.2021.666742. eCollection 2021.
10
Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings.危重症 COVID-19 患者与非 COVID-19 患者的合并感染:临床微生物培养结果比较。
Int J Environ Res Public Health. 2021 Apr 20;18(8):4358. doi: 10.3390/ijerph18084358.